FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Traditional remedies offer opportunities, challenges

The Financial Times delves into the push to develop new therapeutics from traditional Chinese and Indian remedies. There have been successes, including the anti-malarial artemether, which was developed from a plant long used to treat fevers. But researchers note that there are some extraordinary challenges. Natural remedies often rely on a volatile mix of natural ingredients that can have a radically varied effect on different people.

"Traditional medicines can be very dangerous," says Paul Herrling, Novartis' chief of corporate research. "Practitioners had no concept of statistics or of long-term consequences such as treatments that may cause cancer when used over many years."

Novartis and Merck were the only two big pharma companies to stay in the field. And a slate of biotechs joined them, including Nicholas Piramal and Phytopharm. MerLion in Singapore has been active as well after acquiring some of GlaxoSmithKline's traditional assets.

- read the article in the Financial Times

Related Articles:
Studies ponder powers of a plant derivative
A simple method for synthesizing natural compounds
Scripps team finds path to synthesizing natural compounds

More stories about Traditional medicine   China   India   Paul Herrling   Nicholas Piramal   GlaxoSmithKline   pharmaceutical companies   Novartis   Merck  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 1 + 35?
To combat spam, please solve the math question above.